The company boosts its full-year guidance range for adjusted earnings on the heels of a strong second quarter.

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

CVS Health raised its full-year profit forecast after exceeding Wall Street quarterly earnings estimates on Thursday, as ...

CVS Health reported second quarter total revenues increased to $98.9 billion, up 8.4% compared to the prior year period.

Thousands find weight loss relief on Zepbound. Now, they face a choice: Try a different medicine that may have adverse side effects or stop treatment.

CVS Health reports Q2 earnings decline due to litigation charges but boost adjusted EPS guidance, highlighting transformation ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

The company raised its outlook as many insurers are struggling with elevated medical costs in the second quarter.

CVS Health raised its 2025 forecast based on strength in its pharmacy business and improvements in its insurance unit during ...

The injunction is a loss for Gov. Sarah Sanders and a win for CVS, which previously said the state law likely would have ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...